The CVC travel agency has become the largest tourist operator in all of Latin America. It now has its sights set on becoming the largest in the world. The CVC travel agency was founded in 1972 by Guilherme Paulus and Carlos Vicente Cerchiari. Carlos was a politician at the time and was impressed by Guilherme’s ability to please his customers. Carlos left the business venture four years after the founding of the CVC and sold his shares of the company to Guilherme Paulus.
Guilherme Paulus was left to lead the CVC travel agency on his own. The Brazilian born entrepreneur managed to make the CVC into a highly successful company. Even though the CVC was already a success, Guilherme Paulus felt that he could still take it to greater heights with the support of global investment fund. In 2009, Guilherme sold a part of the CVC to the global investment firm, the Carlyle Group. Guilherme is still owner of a third of the company. The CVC travel agency is now able to generate an annual revenue of $5.2 billion.
The next business venture for the successful entrepreneur was the founding of the GJP Hotels and Resorts network in 2005. The GJP has quickly grown to be a successful company and is now in control of 19 hotels all over the country of Brazil. There are 7 hotels in the Southern region of Brazil, 5 hotels in the Southeast region, and 7 in the Northeast region. Guilherme credits the success of the GJP network to its ability to be committed to customer service. The GJP was founded with only one establishment and is now known as one of the largest national hotel chains. It specializes in leisure tourism and events.
Guilherme Paulus moved on to the airline industry after that. In 2006, he acquired the Webjet airline. The small airline had only one aircraft in its fleet at the time of its acquisition. Mr. Paulus managed to transform the small airline into the third largest airline that operates in the country of Brazil. Webjet now has 20 aircraft in its fleet.
Precision medicine is on the rise and Paul Mampilly seems to have discovered the company that is making headways in this field. He believes that Myriad Genetic is a rising global leader in the healthcare sector. The experts believe that precision medicine is a defining method in dealing with disease and it will cause a revolution in disease management and treatment.
This revolutionary method involves tailoring drugs and intervention methods based on the DNA of an individual. Physicians, doctors and healthcare givers need to study and understand the genetic makeup of an individual and determine the most appropriate solution based on what they find out. Death sentences from doctors will be a thing of the past if this is anything to go by.
Many other companies have been involved in customized treatment, testing genetic material and developing the technology to facilitate precision medicine. The $1.5 billion company, established in the early 1990s, is located in Utah in the outskirts of Salt Lake City. Its chief executive has worked in the biotechnology industry for more than two decades. According to Paul Mampilly, he is working on poaching the best scientific brains across the world to actualize their dream.
The mid-Western company is more concerned about the various forms of cancer that continue to claim the lives of many Americans. They conduct DNA sequencing to determine what an individual is predisposed to and what treatment regimen will yield the best results. This technique is far much better compared to the radiotherapy and chemotherapy treatments that have been prescribed to patients in a general way. Follow Paul on twitter.com.
Cancer testing is the main revenue driver for the company which also offers non-cancer testing programs. Colon and breast cancer are the top of their hereditary cancer screening services. Their testing services provide an option for prevention of cancer spread as they allow it to be detected in good time. They also go a long way in cutting down the risk of contracting the disease. Paul Mampilly believes that these services have impressed insurance companies which have not shied away from putting their weight behind Myriad Genetics.
Paul Mampilly first recommended the company’s stock when they sold at $24. Its monopoly in the cancer screening market has seen Myriad rise to a $2.2 billion stock. Despite the slight decline in their share earnings in 2017, analysts expect them to gain rises that will see them hit their former heights. Time will tell whether they will weather the storm of their competitors and keep their place at the top of precision medicine companies. Read more about Paul Mampilly at Talk Markets.
On January 9, 2018, Highland Capital Management announced an endowment in the amount of $10 million to be used to support programs presented under the title “Engage at the Bush Center.” This is not the first contribution by Highland to the Bush Center as Highland has been a substantial support of the programs offered by the center. This gift furthers the purpose of the center as it allows it to continue to present programs with nationally known individuals discussing the important issues of the day. Read more at bloomberg.com.
The announcement of the endowment was made as a joint statement by Kenneth Hersh, CEO of the Bush Center, and James Dondero, co-founder and president of Highland Capital Management. In addition to announcing the gift and first program, a statement was included that James Dondero will be joining the Executive Advisory Council of the Center. The first program in the series which is presented by Highland will be on February 5th and will involve Constitutional Conversations. It is open to the public at no charge but registration is required. These programs normally are filled to capacity so early sign up is encouraged.
Highland Capital has been an early supporter of the George W. Bush Presidential Center. Highland has contributed in excess of $5 million to the center prior to this endowment. These funds helped establish the facilities of the center which opened in 2013. This shows their support of the programs and mission of the center. That support continues with this endowment. Read this article at investopedia.com.
This program which Highland is funding will continue to bring national recognition to the center as a place of intellectual engagement. Serious topics such as how the constitution impacts this country are vital for an educated populace to understand the functions of the Supreme Court in maintaining our constitutional form of government. Participants in the “Engage at the Bush Center” will come away with a new understanding of serious subjects. This knowledge will come due to the generous gift of Highland Capital Management.
By joining the Executive Advisory Council, James Dondero will be in a position to offer his insights into the type of programs that the center should provide. This will provide a welcomed voice to the center as it strives to be a place where important dialogue can occur in a setting similar to an academic one. This type of program is vital to a democracy and an informed publc.